Stocks
Vanda Pharmaceuticals (VNDA) EBITDA US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| EBITDA, bln rub | ? | 25.7 | 30.1 | 45.0 | 9.06 | -10.9 | -32.1 | |
| Changes by years, y/y, % | +10% | +17% | +50% | -80% | -221% | |||
Vanda Pharmaceuticals. EBITDA US GAAP, bln rub
Vanda Pharmaceuticals. EBITDA US GAAP, changes, %
Vanda Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Vanda Pharmaceuticals (VNDA) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -5.42 | -5.94 | -7.01 | -8.18 | -11.0 | -32.1 | |
| Changes by years, y/y, % | -226% | -185% | -362% | +229% | +103% | |||
| Changes by quarters, q/q, % | +118% | +10% | +18% | +17% | +35% | |||
